{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:23:17Z","timestamp":1780604597946,"version":"3.54.1"},"reference-count":124,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","sempedneurjnl.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.spen.2017.08.003","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T23:31:58Z","timestamp":1502753518000},"page":"168-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Autoantibody-Associated Movement Disorders in Children: Proven and Proposed"],"prefix":"10.1016","volume":"24","author":[{"given":"Harvey S.","family":"Singer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2017.08.003_bib1","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/mds.22504","article-title":"Immunopathogenic mechanisms in Tourette syndrome: A critical review","volume":"24","author":"Martino","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2017.08.003_bib2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1055\/s-0033-1358603","article-title":"Autoantibody-associated movement disorders","volume":"44","author":"Mohammad","year":"2013","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.spen.2017.08.003_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S0012162201002055","article-title":"Immune mediated chorea encephalopathy syndrome in childhood","volume":"44","author":"Hartley","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/brain\/awh008","article-title":"Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity","volume":"127","author":"Dale","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.spen.2017.08.003_bib7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-3476(05)80326-9","article-title":"Coma associated with intense bursts of abnormal movements and long-lasting cognitive disturbances: An acute encephalopathy of obscure origin","volume":"121","author":"Sebire","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2017.08.003_bib8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.21807","article-title":"N-methyl-d-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica","volume":"66","author":"Dale","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: Case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib10","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.spen.2017.08.003_bib11","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/ana.23689","article-title":"N-methyl-d-aspartate receptor antibodies in herpes simplex encephalitis","volume":"72","author":"Pruss","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib12","doi-asserted-by":"crossref","first-page":"850-856.e2","DOI":"10.1016\/j.jpeds.2012.10.011","article-title":"Pediatric anti-N-methyl-d-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients","volume":"162","author":"Armangue","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2017.08.003_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.pediatrneurol.2014.10.011","article-title":"Possible autoimmune association between herpes simplex virus infection and subsequent anti-N-methyl-d-aspartate receptor encephalitis: A pediatric patient with abnormal movements","volume":"52","author":"Yushvayev-Cavalier","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib14","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1177\/0883073816643406","article-title":"Approach to the management of pediatric-onset anti-N-methyl-d-aspartate (anti-NMDA) receptor encephalitis: A case series","volume":"31","author":"Brenton","year":"2016","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/dmcn.12321","article-title":"N-methyl-d-aspartate receptor antibody-associated movement disorder without encephalopathy","volume":"56","author":"Hacohen","year":"2014","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/mds.25354","article-title":"The spectrum of movement disorders in children with anti-NMDA receptor encephalitis","volume":"28","author":"Baizabal-Carvallo","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2017.08.003_bib17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/mds.25999","article-title":"Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies","volume":"29","author":"Mohammad","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2017.08.003_bib18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/0883073809343319","article-title":"Expanding spectrum of encephalitis with NMDA receptor antibodies in young children","volume":"25","author":"Lebas","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib19","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/mds.22073","article-title":"The distinctive movement disorder of ovarian teratoma-associated encephalitis","volume":"23","author":"Kleinig","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2017.08.003_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ncl.2014.09.015","article-title":"Movement disorders in systemic diseases","volume":"33","author":"Poewe","year":"2015","journal-title":"Neurol Clin"},{"key":"10.1016\/j.spen.2017.08.003_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/WCO.0b013e328347b307","article-title":"Movement disorders in paraneoplastic and autoimmune disease","volume":"24","author":"Panzer","year":"2011","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/acn.12013","article-title":"Psychiatric phenomena as initial manifestation of encephalitis by anti-NMDAR antibodies","volume":"25","author":"Maat","year":"2013","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.spen.2017.08.003_bib24","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.08.003_bib25","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1212\/WNL.0000000000003758","article-title":"G2A1B3AA receptor antibodies and their clinical associations","volume":"88","author":"Waters","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.08.003_bib26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jamaneurol.2013.4786","article-title":"Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: The first pediatric case of gamma-aminobutyric acid type B receptor autoimmunity","volume":"71","author":"Kruer","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib27","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1212\/NXI.0000000000000232","article-title":"Evidence of a pathogenic role for CD8(+) T cells in anti-GABAB receptor limbic encephalitis","volume":"3","author":"Golombeck","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.spen.2017.08.003_bib28","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: A novel glycine receptor antibody","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.08.003_bib29","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/jnnp.2010.229104","article-title":"Antiglycine-receptor encephalomyelitis with rigidity","volume":"82","author":"Mas","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.spen.2017.08.003_bib30","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: Characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonzalez","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.spen.2017.08.003_bib31","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/jnnp-2012-303807","article-title":"Paediatric autoimmune encephalopathies: Clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens","volume":"84","author":"Hacohen","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.spen.2017.08.003_bib32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jamaneurol.2013.1872","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: The first pediatric case with glycine receptor antibodies","volume":"70","author":"Damasio","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejpn.2016.08.013","article-title":"Focal status epilepticus and progressive dyskinesia: A novel phenotype for glycine receptor antibody-mediated neurological disease in children","volume":"21","author":"Chan","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib34","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1212\/WNL.0000000000001922","article-title":"Clinical relevance of voltage-gated potassium channel-complex antibodies in children","volume":"85","author":"Hacohen","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.08.003_bib35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/WCO.0000000000000444","article-title":"Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies)","volume":"30","author":"Bastiaansen","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib37","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib38","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: The influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.spen.2017.08.003_bib39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2265.2008.03341.x","article-title":"MELAS syndrome, diabetes and thyroid disease: The role of mitochondrial oxidative stress","volume":"70","author":"Tan","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.spen.2017.08.003_bib40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/WNL.0b013e31825f0522","article-title":"Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis","volume":"79","author":"Tofaris","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.08.003_bib41","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1212\/WNL.0000000000000372","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: A new variant with DPPX antibodies","volume":"82","author":"Balint","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.08.003_bib42","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/brain\/aws256","article-title":"Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders","volume":"135","author":"Dale","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.spen.2017.08.003_bib43","doi-asserted-by":"crossref","first-page":"e0001","DOI":"10.5041\/RMMJ.10276","article-title":"Neuropsychiatric systemic lupus erythematosus involvement: Towards a tailored approach to our patients?","volume":"8","author":"Faria","year":"2017","journal-title":"Rambam Maimonides Med J"},{"key":"10.1016\/j.spen.2017.08.003_bib44","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.braindev.2015.01.008","article-title":"Mixed movements disorders as an initial feature of pediatric lupus","volume":"37","author":"Mrabet","year":"2015","journal-title":"Brain Dev"},{"key":"10.1016\/j.spen.2017.08.003_bib45","doi-asserted-by":"crossref","DOI":"10.1177\/0961203317700484","article-title":"Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: A longitudinal analysis","volume":"26","author":"Lythgoe","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.spen.2017.08.003_bib46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-3476(96)70064-1","article-title":"Clinical characteristics of antiphospholipid antibody syndrome in children","volume":"129","author":"von Scheven","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2017.08.003_bib47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/BOR.0000000000000369","article-title":"From mechanism to therapies in systemic lupus erythematosus","volume":"29","author":"Paley","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.spen.2017.08.003_bib48","doi-asserted-by":"crossref","first-page":"i24","DOI":"10.1093\/rheumatology\/kew447","article-title":"Paediatric systemic lupus erythematosus: Insights from translational research","volume":"56","author":"Wright","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.spen.2017.08.003_bib49","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1161\/01.STR.31.12.3079-b","article-title":"Brain MRI in patients with past lupus-associated chorea","volume":"31","author":"Galanaud","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.spen.2017.08.003_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/RLU.0b013e318192c4d2","article-title":"FDG PET brain imaging in neuropsychiatric systemic lupus erythematosis with choreic symptoms","volume":"34","author":"Krakauer","year":"2009","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.spen.2017.08.003_bib51","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: Understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.spen.2017.08.003_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11926-016-0568-x","article-title":"Non-stroke central neurologic manifestations in antiphospholipid syndrome","volume":"18","author":"Yelnik","year":"2016","journal-title":"Curr Rheumatol Rep"},{"issue":"Suppl 1","key":"10.1016\/j.spen.2017.08.003_bib53","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(17)30066-X","article-title":"Antiphospholipid syndrome","volume":"151","author":"Cervera","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.spen.2017.08.003_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2017.02.009","article-title":"Diagnosis and treatment of antiphospholipid syndrome in childhood: A review","author":"Rumsey","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.spen.2017.08.003_bib55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.autrev.2015.01.002","article-title":"The relevance of \u201cnon-criteria\u201d clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features","volume":"14","author":"Abreu","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.spen.2017.08.003_bib56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/archdischild-2012-302404","article-title":"Fitting and flailing: Recognition of paediatric antiphospholipid syndrome","volume":"99","author":"Freeman","year":"2014","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.spen.2017.08.003_bib57","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00702-013-1023-z","article-title":"Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome","volume":"120","author":"Baizabal-Carvallo","year":"2013","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.spen.2017.08.003_bib58","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fneur.2012.00150","article-title":"Antiphospholipid-related chorea","volume":"3","author":"Peluso","year":"2012","journal-title":"Front Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib59","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pediatrneurol.2016.02.003","article-title":"Hashimoto encephalopathy presenting with stroke-like episodes in an adolescent female: A case report and literature review","volume":"59","author":"Graham","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.pediatrneurol.2014.12.005","article-title":"Thyroid-related neurological disorders and complications in children","volume":"52","author":"Nandi-Munshi","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib61","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.autrev.2016.01.014","article-title":"Hashimoto's encephalopathy: A rare proteiform disorder","volume":"15","author":"Montagna","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.spen.2017.08.003_bib62","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jca.21353","article-title":"The use of plasma exchange in Hashimoto's encephalopathy: A case report and review of the literature","volume":"30","author":"Cook","year":"2015","journal-title":"J Clin Apher"},{"key":"10.1016\/j.spen.2017.08.003_bib63","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.wnp.0000214542.21735.49","article-title":"EEG changes in a patient with steroid-responsive encephalopathy associated with antibodies to thyroperoxidase (SREAT, Hashimoto's encephalopathy)","volume":"23","author":"Rodriguez","year":"2006","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.spen.2017.08.003_bib64","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/WNL.41.2_Part_1.228","article-title":"Hashimoto's encephalopathy: A steroid-responsive disorder associated with high anti-thyroid antibody titers\u2014Report of 5 cases","volume":"41","author":"Shaw","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.08.003_bib65","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1651-2227.2008.00686.x","article-title":"Unexplained seizures, confusion or hallucinations: Think Hashimoto encephalopathy","volume":"97","author":"Alink","year":"2008","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.spen.2017.08.003_bib66","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00431-014-2391-6","article-title":"Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Case report of reversible coma and status epilepticus in an adolescent patient and review of the literature","volume":"173","author":"Hilberath","year":"2014","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.spen.2017.08.003_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2009.11.015","article-title":"Sydenham's chorea: A practical overview of the current literature","volume":"43","author":"Oosterveer","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/B978-0-444-52014-2.00014-8","article-title":"Sydenham's chorea","volume":"100","author":"Cardoso","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib69","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.parkreldis.2013.10.029","article-title":"Psychiatric disorders in persistent and remitted Sydenham's chorea","volume":"20","author":"Moreira","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.spen.2017.08.003_bib70","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.parkreldis.2008.01.014","article-title":"Frequency and significance of vocalizations in Sydenham's chorea","volume":"15","author":"de Teixeira","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.spen.2017.08.003_bib71","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mds.26109","article-title":"Where does chorea come from? cortical excitability findings challenge classic pathophysiological concepts","volume":"30","author":"Hallett","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2017.08.003_bib72","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/mds.25928","article-title":"Changes in motor cortical excitability in patients with Sydenham's chorea","volume":"30","author":"Khedr","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2017.08.003_bib73","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1084\/jem.144.4.1094","article-title":"Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever","volume":"144","author":"Husby","year":"1976","journal-title":"J Exp Med"},{"key":"10.1016\/j.spen.2017.08.003_bib74","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1212\/WNL.59.2.227","article-title":"Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea","volume":"59","author":"Church","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.08.003_bib75","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm892","article-title":"Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea","volume":"9","author":"Kirvan","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.spen.2017.08.003_bib76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/08916930500484757","article-title":"Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea","volume":"39","author":"Kirvan","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.spen.2017.08.003_bib77","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jneuroim.2006.06.017","article-title":"Antibody-mediated neuronal cell signaling in behavior and movement disorders","volume":"179","author":"Kirvan","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.spen.2017.08.003_bib78","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/apha.12614","article-title":"Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: A review of Sydenham chorea and beyond","volume":"216","author":"Cunningham","year":"2016","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.spen.2017.08.003_bib79","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.4049\/jimmunol.178.11.7412","article-title":"Tubulin is a neuronal target of autoantibodies in Sydenham's chorea","volume":"178","author":"Kirvan","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.spen.2017.08.003_bib80","doi-asserted-by":"crossref","first-page":"e73516","DOI":"10.1371\/journal.pone.0073516","article-title":"Dopamine receptor autoantibodies correlate with symptoms in Sydenham's chorea","volume":"8","author":"Ben-Pazi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.spen.2017.08.003_bib81","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/npp.2012.56","article-title":"Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: A novel rat model of Sydenham chorea and related neuropsychiatric disorders","volume":"37","author":"Brimberg","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.spen.2017.08.003_bib82","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.4049\/jimmunol.1102592","article-title":"Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: Implications in human disease","volume":"191","author":"Cox","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.spen.2017.08.003_bib83","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/WNL.0b013e3182181090","article-title":"Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome","volume":"76","author":"Brilot","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.08.003_bib84","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12031-011-9559-6","article-title":"Striatal microinjection of Sydenham chorea antibodies: Using a rat model to examine the dopamine hypothesis","volume":"46","author":"Ben-Pazi","year":"2012","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.spen.2017.08.003_bib85","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbi.2014.02.009","article-title":"Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats","volume":"38","author":"Lotan","year":"2014","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.spen.2017.08.003_bib86","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/mp.2009.77","article-title":"Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection","volume":"15","author":"Yaddanapudi","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.spen.2017.08.003_bib87","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5334\/tohm.376","article-title":"Treatment of Sydenham's chorea: A review of the current evidence","volume":"7","author":"Dean","year":"2017","journal-title":"Tremor Other Hyperkinet Disord"},{"key":"10.1016\/j.spen.2017.08.003_bib88","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/ajp.155.2.264","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases","volume":"155","author":"Swedo","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.spen.2017.08.003_bib89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/cap.2014.0084","article-title":"Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): Recommendations from the 2013 PANS Consensus Conference","volume":"25","author":"Chang","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.spen.2017.08.003_bib90","series-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)","author":"Orefici","year":"2016"},{"key":"10.1016\/j.spen.2017.08.003_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2005\/795343","article-title":"D8\/17 monoclonal antibody: An unclear neuropsychiatric marker","volume":"16","author":"Morer","year":"2005","journal-title":"Behav Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib92","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1176\/appi.ajp.157.2.281","article-title":"MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection","volume":"157","author":"Giedd","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.spen.2017.08.003_bib93","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/0883073814543303","article-title":"Evaluation of basal ganglia and thalamic inflammation in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection and tourette syndrome: A positron emission tomographic (PET) study using 11C-[R]-PK11195","volume":"30","author":"Kumar","year":"2015","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib94","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jpeds.2011.11.040","article-title":"Moving from PANDAS to CANS","volume":"160","author":"Singer","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2017.08.003_bib95","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0887-8994(00)00131-4","article-title":"Infection: A stimulus for tic disorders","volume":"22","author":"Singer","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib96","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaac.2010.10.011","article-title":"Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: A prospective longitudinal study","volume":"50","author":"Leckman","year":"2011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.08.003_bib97","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00006454-200205000-00014","article-title":"Clinical use and interpretation of group A streptococcal antibody tests: A practical approach for the pediatrician or primary care physician","volume":"21","author":"Shet","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.spen.2017.08.003_bib98","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1542\/peds.2007-1307","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcus: Comparison of diagnosis and treatment in the community and at a specialty clinic","volume":"122","author":"Gabbay","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2017.08.003_bib99","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5334\/tohm.243","article-title":"Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS): Experience at a tertiary referral center","volume":"5","author":"Helm","year":"2015","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"10.1016\/j.spen.2017.08.003_bib100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/mds.20107","article-title":"The PANDAS hypothesis: Losing its bite?","volume":"19","author":"Kurlan","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2017.08.003_bib101","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1542\/peds.101.1.86","article-title":"Antistreptolysin O and anti-deoxyribonuclease B titers: Normal values for children ages 2 to 12 in the United States","volume":"101","author":"Kaplan","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2017.08.003_bib102","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1542\/peds.2007-2657","article-title":"Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: A prospective blinded cohort study","volume":"121","author":"Kurlan","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2017.08.003_bib103","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/archpedi.158.9.848","article-title":"Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children?","volume":"158","author":"Perrin","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.spen.2017.08.003_bib104","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1542\/peds.2004-2058","article-title":"Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder","volume":"116","author":"Mell","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2017.08.003_bib105","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/CHI.0b013e3181825a3d","article-title":"Neuropsychiatric disorders associated with streptococcal infection: A case-control study among privately insured children","volume":"47","author":"Leslie","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.08.003_bib106","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.0b013e3181bd10fd","article-title":"Streptococcal infection, Tourette syndrome, and OCD: Is there a connection?","volume":"73","author":"Schrag","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.08.003_bib107","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/039463201402700307","article-title":"Pediatric autoimmune neuropsychiatric disorder associated with group a streptococcal infection: The role of surgical treatment","volume":"27","author":"Pavone","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.spen.2017.08.003_bib108","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/jamaoto.2014.3407","article-title":"The role of tonsillectomy in the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)","volume":"141","author":"Demesh","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.spen.2017.08.003_bib109","article-title":"Tonsillectomy remains a questionable option for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). GMS Curr Top Otorhinolaryngol","volume":"15","author":"Windfuhr","year":"2016","journal-title":"Head Neck Surg"},{"key":"10.1016\/j.spen.2017.08.003_bib110","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0006-3223(99)00020-7","article-title":"A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections","volume":"45","author":"Garvey","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.spen.2017.08.003_bib111","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.biopsych.2004.12.035","article-title":"Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders","volume":"57","author":"Snider","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.spen.2017.08.003_bib112","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","article-title":"Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood","volume":"354","author":"Perlmutter","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2017.08.003_bib113","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/cap.2014.0067","article-title":"Use of intravenous immunoglobulin in the treatment of twelve youths with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections","volume":"25","author":"Kovacevic","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.spen.2017.08.003_bib114","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jaac.2016.06.017","article-title":"Randomized, controlled trial of intravenous immunoglobulin for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections","volume":"55","author":"Williams","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.08.003_bib115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/cap.2014.0080","article-title":"Therapeutic plasma apheresis as a treatment for 35 severely ill children and adolescents with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections","volume":"25","author":"Latimer","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.spen.2017.08.003_bib116","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/jnnp.74.5.602","article-title":"Tourette's syndrome: A cross sectional study to examine the PANDAS hypothesis","volume":"74","author":"Church","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.spen.2017.08.003_bib117","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneuroim.2005.10.014","article-title":"Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease","volume":"172","author":"Dale","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.spen.2017.08.003_bib118","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/01.wnl.0000183223.69946.f1","article-title":"Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls","volume":"65","author":"Singer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.08.003_bib119","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1542\/peds.2007-2658","article-title":"Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections","volume":"121","author":"Singer","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2017.08.003_bib120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0887-8994(03)00413-2","article-title":"Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection","volume":"30","author":"Pavone","year":"2004","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.08.003_bib121","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2008.08.032","article-title":"Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls","volume":"276","author":"Morris","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.spen.2017.08.003_bib122","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2013.09.010","article-title":"Anti-streptococcal, tubulin, and dopamine receptor 2 antibodies in children with PANDAS and Tourette syndrome: Single-point and longitudinal assessments","volume":"264","author":"Morris-Berry","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.spen.2017.08.003_bib123","doi-asserted-by":"crossref","first-page":"e0120499","DOI":"10.1371\/journal.pone.0120499","article-title":"Neuronal antibody biomarkers for Sydenham's chorea identify a new group of children with chronic recurrent episodic acute exacerbations of tic and obsessive compulsive symptoms following a streptococcal infection","volume":"10","author":"Singer","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.spen.2017.08.003_bib124","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/mds.10522","article-title":"Striatal microinfusion of Tourette syndrome and PANDAS sera: Failure to induce behavioral changes","volume":"19","author":"Loiselle","year":"2004","journal-title":"Mov Disord"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117300931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117300931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T05:28:46Z","timestamp":1659331726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909117300931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":124,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1071909117300931"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2017.08.003","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibody-Associated Movement Disorders in Children: Proven and Proposed","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2017.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}